In tumor samples, PD-1 and PD-L1 mainly expressed in T cells and tumor cells, respectively, and tumors exploit their interaction to escape the immune system by counteracting the stimulatory signals from the interaction between T cell receptor (TCR) and major histocompatibility complex (MHC) and other costimulatory signals (2–4). The gene discussed is PDCD1; the disease is neoplasm.